SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001903596-22-000393
Filing Date
2022-06-23
Accepted
2022-06-22 20:23:58
Documents
17
Period of Report
2022-06-22
Items
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 sfsfpmi8k062222.htm   iXBRL 8-K 33861
2 sfsfpmi8k062222ex99_1.htm EX-99.1 2683
6 GRAPHIC ex99_1-001.jpg GRAPHIC 228947
7 GRAPHIC ex99_1-002.jpg GRAPHIC 217942
8 GRAPHIC ex99_1-003.jpg GRAPHIC 155867
9 GRAPHIC ex99_1-004.jpg GRAPHIC 111861
  Complete submission text file 0001903596-22-000393.txt   1187448

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fpmi-20220622.xsd EX-101.SCH 2947
4 XBRL LABEL FILE fpmi-20220622_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE fpmi-20220622_pre.xml EX-101.PRE 22351
11 EXTRACTED XBRL INSTANCE DOCUMENT sfsfpmi8k062222_htm.xml XML 3168
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-147193 | Film No.: 221033361
SIC: 2835 In Vitro & In Vivo Diagnostic Substances